Liang Peng

10PUBLICATIONS
25CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersNutritional epidemiologyInfant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Nov 12, 2025
TRIM46 promotes chemoresistance of ovarian cancer via activating PHLPP2/PI3K/AKT pathway.

Liang Peng, Limei Liu, Ling Xu

|Aug 14, 2024
Impact of Extracellular Matrix-Related Genes on the Tumor Microenvironment and Prognostic Indicators in Esophageal Cancer: A Comprehensive Analytical Study.

Yinghong Wu, Wenjie Hu, Zhihong Jia

|Jun 06, 2024
Exploring the link: Systemic immune-inflammation index as a marker in endometriosis-Insights from the NHANES 2001-2006 cross-sectional study.

Liang Peng, Xiaohan Luo, Baodi Cao

|Jan 08, 2024
Multidimensional Analysis of PANoptosis-Related Molecule CASP8: Prognostic Significance, Immune Microenvironment Effect, and Therapeutic Implications in Hepatocellular Carcinoma.

Fei Peng, Fang Zhu, Baodi Cao

|Feb 23, 2023
Relationship between Platelet-to-Lymphocyte Ratio and Lymphocyte-to-Monocyte Ratio with Spontaneous Preterm Birth: A Systematic Review and Meta-analysis.

Liang Peng, Baodi Cao, Fangpeng Hou

|Feb 08, 2022
LINC02273 Promotes Hepatocellular Carcinoma Progression via Retaining β-Catenin in the Nucleus to Augment Wnt Signaling.

Liang Peng, Rong Ye, Xiansen Zhu

Pageof 2

Frequent Collaborators

3 joint publications

Baodi Cao

1 joint publications

Rong Ye

1 joint publications

Xiansen Zhu

1 joint publications

Yuankang Xie